FDA-approved small-molecule kinase inhibitors [PDF]
, 2015 Clausen, Mads Hartvig +2 more
core +1 more source
Treatment of Livedoid Vasculopathy with the Janus Kinase Inhibitors: A Case Series. [PDF]
Case Rep DermatolZhao G, Liu Y, Ni J, Song Z.
europepmc +1 more source
Research progress in electrochemical determination of Janus kinase inhibitors and proposals for amplifying clinical applicability. [PDF]
Mikrochim ActaMikus P, Hanko M, Zelinkova Z, Labuda J.
europepmc +1 more source
Janus kinase inhibitors: another potential for uveitis treatment? [PDF]
Ann Eye SciEmami S, Kaisari E, Janetos TM.
europepmc +1 more source
Association of Venous Thromboembolism Risk with Atopic Dermatitis and Janus Kinase Inhibitors Treatment: A Mendelian Randomization Study. [PDF]
Clin Appl Thromb HemostChen Z, Wang S, Wang Y.
europepmc +1 more source
Treating active rheumatoid arthritis with Janus kinase inhibitors [PDF]
The Lancet, 2017 Scott, David L, Stevenson, Matt D
openaire +4 more sources
Real-world comparative effectiveness of sarilumab versus Janus kinase inhibitors as monotherapy in rheumatoid arthritis. [PDF]
Arthritis Res TherNozaki Y +20 more
europepmc +1 more source
Next-generation Janus kinase inhibitors: Integrating synthetic innovation, structural biology, and computational design for precision drug discovery. [PDF]
Pharm Sci AdvKarunakar KK +4 more
europepmc +1 more source
Systemic Inflammation Marker Alterations in Severe Alopecia Areata Patients Treated with Janus Kinase Inhibitors. [PDF]
J Clin MedSahin G, Aydin F, Pancar Yuksel E.
europepmc +1 more source
Janus kinase inhibitors in pulmonary and extra-pulmonary sarcoidosis: A case series and a systematic review of the literature. [PDF]
Sarcoidosis Vasc Diffuse Lung DisQuaggetto M +7 more
europepmc +1 more source